Hexagon Capital Partners LLC Has $196,000 Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Hexagon Capital Partners LLC lowered its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 19.3% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 9,052 shares of the pharmacy operator’s stock after selling 2,160 shares during the quarter. Hexagon Capital Partners LLC’s holdings in Walgreens Boots Alliance were worth $196,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Highlander Capital Management LLC bought a new stake in Walgreens Boots Alliance during the 4th quarter worth about $26,000. Pineridge Advisors LLC acquired a new stake in shares of Walgreens Boots Alliance during the 4th quarter worth approximately $26,000. Venturi Wealth Management LLC raised its stake in shares of Walgreens Boots Alliance by 1,241.8% during the fourth quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 981 shares during the last quarter. Rocky Mountain Advisers LLC acquired a new position in Walgreens Boots Alliance in the fourth quarter valued at approximately $30,000. Finally, Quest Partners LLC bought a new position in Walgreens Boots Alliance in the fourth quarter valued at approximately $30,000. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Down 4.3 %

NASDAQ:WBA opened at $11.58 on Tuesday. Walgreens Boots Alliance, Inc. has a 52-week low of $11.48 and a 52-week high of $31.32. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.31 and a current ratio of 0.65. The stock has a 50-day simple moving average of $16.49 and a 200 day simple moving average of $20.14. The company has a market cap of $10.00 billion, a PE ratio of -1.72, a PEG ratio of 0.82 and a beta of 0.72.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 EPS for the quarter, missing the consensus estimate of $0.68 by ($0.05). Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The business had revenue of $36.40 billion for the quarter, compared to analyst estimates of $35.94 billion. During the same quarter in the previous year, the company posted $1.00 EPS. The business’s revenue for the quarter was up 2.8% compared to the same quarter last year. On average, sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 2.94 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, June 12th. Stockholders of record on Tuesday, May 21st were issued a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 8.64%. The ex-dividend date was Monday, May 20th. Walgreens Boots Alliance’s payout ratio is presently -14.84%.

Wall Street Analyst Weigh In

WBA has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft dropped their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a research report on Wednesday, April 3rd. Truist Financial dropped their price objective on Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating for the company in a report on Friday. Morgan Stanley reduced their target price on Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating on the stock in a report on Friday. UBS Group lowered their price target on Walgreens Boots Alliance from $22.00 to $17.00 and set a “neutral” rating for the company in a research note on Monday, June 24th. Finally, Evercore ISI reduced their price objective on shares of Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating on the stock in a research note on Friday. Four equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $19.00.

Insider Activity at Walgreens Boots Alliance

In other news, Director Inderpal S. Bhandari purchased 3,000 shares of the company’s stock in a transaction on Thursday, April 11th. The shares were purchased at an average cost of $18.05 per share, with a total value of $54,150.00. Following the completion of the transaction, the director now owns 3,000 shares of the company’s stock, valued at approximately $54,150. The transaction was disclosed in a filing with the SEC, which is available through this link. 17.40% of the stock is owned by company insiders.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.